Drug discovery > Target Discovery Products & Reviews

Fast track precise spatial multiplexing

Target Sufficiency® is the ability of a target system to respond to a therapeutic. It reflects the abundance and forms of the drug target protein, as well as other key system proteins that connect the target to disease phenotypes and enable response. Assessment of the target system requires an analysis platform that can simultaneously capture multiple precise protein measurements.

Flare™ is a ligand-based and structure-based drug design platform. Through high-resolution 3D visualization and in-depth analysis of target structures and potential ligands, Flare enables users to optimize and prioritize new molecules efficiently and effectively.

Flare™ enables the production of high-resolution 3D graphics of your ligands and proteins for publications and communication of results.

Flare™ FEP enables research chemists to refine docking results, making the right structure-based design choices for lead optimization with confidence.

Spark™ is a powerful scaffold hopping and bioisosteric replacement solution that generates highly innovative ideas for your project to explore chemical space and escape IP and toxicity traps.

Blaze™ is an advanced virtual screening platform enabling you to dramatically increase your wet screening hit rate at a fraction of the cost.

Torx® connects medicinal chemistry teams and CROs across the DMTA cycle to drive productivity in small molecule discovery in a secure cloud-based platform.

Cresset Discovery is a premier computational chemistry CRO with a proven track record delivering high impact drug discovery projects. From ideation to synthesis and biological results, their expert CADD scientists are the best at what they do. Working alongside you from the ground up, they apply the best in silico techniques, and give expert advice and guidance, to accelerate your assets through the pipeline.

sTNFRr1 is a predictive marker of Chronic Kidney Disease (CKD) and End Stage Renal Disease (ESRD)